Clinical and laboratory evaluation of different dosage forms of baneocin for the treatment of wound infection.
Blatun
L A
LA
Zhukov
A O
AO
Amiraslanov
Iu A
IuA
Terekhova
R P
RP
Agafonov
V A
VA
Askerov
N G
NG
Malina
V A
VA
Ushakov
A A
AA
Ivanov
A P
AP
Fedotov
S V
SV
Pechetov
A A
AA
Tertitskaia
A B
AB
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001414:Bacitracin / Q000008:administration & dosage* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D006090:Gram-Negative Bacteria / Q000187:drug effects / Q000302:isolation & purification*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D006094:Gram-Positive Bacteria / Q000187:drug effects / Q000302:isolation & purification*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000008:administration & dosage* / Q000627:therapeutic use; D013530:Surgical Wound Infection / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects*; D055815:Young Adult
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D001414:Bacitracin; D009355:Neomycin